Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause

Area of Science:

• Endocrinology
• Reproductive Medicine
• Menopause Research

Background:

• Menopause is associated with hypoestrogenism, leading to decreased levels of dehydroepiandrosterone sulfate (DHEA-S) and ACTH.
• The precise relationship between estrogen deficiency and these hormonal changes requires further elucidation.

Purpose of the Study:

• To investigate the role of hypoestrogenism in menopause on circulating DHEA-S and ACTH levels.
• To determine the effect of hormone replacement therapy (HRT) on DHEA-S, ACTH, and cortisol concentrations in postmenopausal women.

Main Methods:

• A prospective, non-blinded study involving 25 postmenopausal women (aged 47-60).
• Participants received oral conjugated equine estrogen (CEE) for 21 days, followed by chlormadinone acetate for 5 days, over three cycles.
• Hormonal levels (DHEA-S, ACTH, cortisol) were measured before and after HRT.

Main Results:

• HRT significantly increased DHEA-S levels (P<0.001) and moderately increased ACTH (P<0.05) and cortisol (P<0.01) levels.
• Positive correlations were observed between 17 beta-estradiol and ACTH, cortisol, and DHEA-S.
• A highly significant correlation (P<0.001) was found between ACTH and DHEA-S post-HRT.

Conclusions:

• Hormone replacement therapy elevated DHEA-S, ACTH, and cortisol concentrations in postmenopausal women.
• These findings suggest HRT may stimulate the pituitary gland in the context of baseline hypoestrogenism.
• Further research is needed to fully understand the underlying mechanisms of this observed hormonal response.